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Introduction
      Lung cancer is a common and frequently lethal complication 
of COPD. Cross-sectional studies show that in subjects diagnosed 
with lung cancer, 40–70% have COPD [1-3]. Papi et al. [4] found 
that the presence of COPD increased the risk of squamous cell 
cancer more than four fold. In a large US study, Mannino et al. [5] 
reported that moderate to severe obstructive lung disease was 
associated with a hazard ratio of  2.8 (95% confidence interval, 
1.8-4.4) for incident lung cancer. In a large cohort of male Swed-
ish construction workers, the rates of squamous and small cell 
lung cancer were increased, with relative risks of 1.5 and 2.2 for 
those with mild and moderate-to-severe COPD, respectively, 
indicating a “dose-response” [6]. The Inhaled Steroids in Obstruc-
tive Lung Disease (ISOLDE) investigators [7] reported that 14% 
of deaths in patients with moderate to severe COPD were due to 
lung cancer. In a large cohort  of 1,927 patients with a first record-
ed diagnosis of COPD included in the General Practice 
Research Database,  the relative risk of lung cancer was 3.33 
(95% confidence interval, 2.33-4.75) [8]. Interestingly, this 
excess risk persisted after adjustment for age, sex and smoking 
status suggesting that COPD is itself an important risk factor, 
rather than merely being a surrogate marker of smoking [9].
      Resection rate and survival of British lung cancer patients 
remain poor by international comparison [10]. Whilst the cause 
of this is uncertain, the reform of lung cancer management after 
primary care referral has had limited impact. British lung 
cancer patients are identified at a later stage [11] likely to reflect 
late presentation of symptomatic disease and/or late recognition 
of symptoms in primary care. Furthermore, the outcome of 
British lung cancer patients with COPD has been found to be 
substantially worse than for those without COPD, but whether 
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Telephone Follow-Up to Identify Incident Lung Cancer Symptoms in 
COPD Patients
Abstract
Background: COPD patients are at very high risk of lung cancer, yet new respiratory symptoms of lung cancer 
may be particularly hard to identify. Aim: We sought to assess the feasibility of actively seeking lung cancer 
symptoms to improve the timeliness of diagnosis in this group. Design and setting: Observational study to evalu-
ate the feasibility and practicability of the intervention. Patients were recruited from a primary care COPD regis-
ter and were contacted by telephone 4-monthly over 12 months. Chest X-ray rates were assessed over the 20 
months before, during the intervention and for 20 months following it, in both the study group and in patients on 
the register who did not volunteer for the intervention. Results: Most symptoms were identified at the first call, 
with 13 (17%) subjects admitting to a new persistent cough and 7 (9%) to a change in their cough. As a result of 
symptoms identified on the first call, 21 (27%) of the participating patients were referred for a chest X-ray and 4 
(5%) were referred urgently to secondary care. Incident symptoms continued frequently to be identified at all 
subsequent calls, with an overall total of 49% of patients qualifying for and receiving a chest X-ray. Interestingly, 
the chest X-ray rate remained significantly elevated for the 20 months following the intervention, whilst there 
appeared to be little change in the non-study COPD patients. Conclusion: The intervention was readily practica-
ble and lung cancer symptoms were frequently identified. The intervention may have resulted in a behavior 
change leading to a persistently higher chest X-ray rate, although the comparator group was not a formal control 
group and further assessment in a randomized control trial appears justified.
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this is due to delayed presentation, to comorbidity or other 
factors is uncertain [12]. Identifying early lung cancer in COPD 
poses a particular challenge, because of the background noise 
of chronic respiratory symptoms. Even when new respiratory 
symptoms are identified, they are prone to being attributed to an 
exacerbation of COPD, rather than a second pathology. 
       Early diagnosis remains as important in patients with COPD 
as those without. Many patients with COPD may still be 
suitable for radical therapy, including surgical resection and 
radiotherapy. Even when not, earlier diagnosis has numerous 
potential benefits, including increasing eligibility for palliative 
treatments and addressing psychosocial issues. 
      We previously reported a social marketing study that showed 
that chest X-ray rates were significantly increased, with a trend 
to more lung cancer diagnoses, by increasing awareness of 
cough in particular as a lung cancer symptom in the general 
public and in primary care [13]. In the present study, we have 
sought to extend the reach of symptom identification by active-
ly enquiring about lung cancer symptoms. COPD registers are 
now well established in primary care, supported by the Quality 
Outcomes Framework. We hypothesized that a pro-active 
review of respiratory symptoms in patients with COPD may 
facilitate earlier identification and diagnosis of lung cancer in 
this patient group. Key questions to assess feasibility were 
willingness of participants to be recruited, follow-up rates, 
duration of call times and nurse time required.
Methods
     The study was designed to assess the feasibility of using 
regular, telephone-based review of respiratory symptoms 
experienced by patients registered in a primary care COPD 
database, to identify the emergence of NICE-recommended 
lung cancer symptoms. The outcomes of main interest were: a) 
recruitment rate b) staff-time required to undertake the 
telephone interviews, to facilitate the resourcing of a definitive 
study and to inform the health economic evaluation c) yields of 
the outcome measures. The ideal outcome measures would be 
the number of cancers identified as a result of the intervention, 
radical treatment rates and, ultimately, mortality. Given the 
small scale of this pilot study, no case of cancer was expected to 
be identified, but the rates of chest X-rays requiring further 
evaluation to exclude lung cancer was expected to be evaluable 
and was chosen as the primary outcome measure. 
Inclusion criteria
      Inclusion on a primary care COPD register; provision of 
informed consent; ability regularly to be contacted by 
telephone; age 40 years or above.
Exclusion criteria
      Current or previous (within 5 years) lung cancer diagnosis; 
presence of any other condition likely to cause death within the 
next 3 years, including active malignancy (excluding skin 
cancer, superficial bladder cancer and stable CLL); severe 
cardiac failure (NYHA IV); dementia or active psychosis; 
unwillingness to give informed consent; inability to communi-
cate in English.  Conducting telephone interviews with non-En-
glish speaking participants was regarded as being impractical, 
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at least without the use of expensive and cumbersome interpret-
ing resources.
      The study was undertaken in a single, large, primary health 
care practice in Conisbrough, a socially deprived town within 
the metropolitan borough of Doncaster, UK, from August 2013 
to December 2014.  The exploratory nature of the study and the 
resources available determined that only one practice was used 
and this determined the number of participants. A staged 
consent process was employed. Potentially eligible patients 
were sent an invitation letter and information sheet regarding 
participation in the study, along with a consent form, in which 
consent or otherwise could be indicated, for return in a stamped 
addressed envelope. The invitation letter was sent from and 
returned to the practice. Patients returning the form with provi-
sional consent were then telephoned to confirm the consent by 
the practice nurse (DB). 
      At the first telephone contact, baseline data were collected, 
including smoking history, the type and frequency of usual 
respiratory symptoms (specifically cough, sputum production, 
haemoptysis, wheeze and breathlessness). Thereafter, the nurse 
contacted the patient 4-monthly for 12 months to identify the 
emergence of the features recommended by NICE as requiring 
a chest X-ray. It was asked specifically whether: 
     a new cough or a change in the character of a longstanding 
      cough had developed; 
     there had been haemoptysis; 
     there had been an increase in breathlessness;
     there had been a new chest pain;
     there had been unintentional loss of 2 kg or more in weight.
         If the symptom had persisted for less than 3 weeks, a repeat 
call was scheduled to check whether it had resolved. If any of 
the NICE criteria were met, subjects were asked to attend for a 
chest X-ray, unless they had had a normal chest X-ray in the 
previous 2 months. If the chest X-ray was normal, subjects were 
asked to make an appointment with the general practitioner for 
evaluation including the need for a secondary care referral. The 
questions to be asked in the interviews were provided in a 
Microsoft Access © database.
       Chest X-ray reports were returned in the normal way to the 
practice. If a report raised the possibility of lung cancer it was 
copied to the local lung cancer multi-disciplinary team and an 
urgent outpatient appointment arranged, in line with our usual 
practice. 
Statistical analyses
       The proportion of patients referred for a chest X-ray for 
each month in the study was calculated.  Descriptive statistics 
were calculated for the pre-, during, and post-intervention 
period for the intervention and non-intervention cohorts.
      Linear regressions were carried out to establish whether 
rates of referrals varied systematically over time or seasons in 
the pre- or post- intervention intervals, and to establish the base 
referral rate (intercept) for each of these intervals. These were 
performed separately for pre- and post- intervention intervals, 
for both intervention and non-intervention cohorts.
Results
Recruitment
Br J Cancer Res 2019,2:4
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     281 patients identified on the COPD register meeting the 
inclusion/ exclusion criteria were approached.  Only 77 (27%) 
consented and were contactable for the first call. The character-
istics of the study participants are shown in Table 1. 
Delivery of the intervention
       Call durations are shown in Table 2. The first call took less 
than 5 minutes in 13 (18%), 5-10 minutes in 54 (74%) and 
10-15 minutes in 6 (8%) cases. The subsequent calls were 
quicker due to the fewer questions being asked, with only 1-3% 
taking longer than 10 minutes and none more than 15 minutes. 
      Some difficulty was found contacting patients for follow up 
calls: 8 patients were unable to be contacted for call 2 and of 
these 4 patients were not contactable at the third call either, 
although 2 of these were contacted for the final call. Of the 69 
patients contacted at both first and second calls, 33 were not 
contactable for the fourth call, one having died and another 
withdrawing. Of the remaining 31, 14 were contactable for the 
final call. 
Symptoms and referrals
     The symptoms identified are reported in Table 3. Most symp-
toms were found at the first call, with 13 (17%) subjects admit-
ting to a new persistent cough and 7 (9%) to a change in their 
cough that had been present for 3 weeks or longer. 4 (5%) had 
had haemoptysis, 6 (8%) chest pains, and 8 (10%) had lost more 
than 2 kg in weight. As a result of symptoms identified on the 
first call, 21 (27%) patients were referred for a chest X-ray and 
4 (5%) were referred urgently to secondary care as a possible 
case of lung cancer. 
    18 patients required additional calls to check whether a new 
cough identified at a previous call had persisted for 3 weeks. In 
7 (39%) of these the symptom had fully resolved, 7 (39%) 
patients were reviewed by the GP. Six (33%) patients received 
a chest X-ray, 2 after the GP’s review. Incident symptoms 
continued frequently to be identified at all subsequent calls, 
with an overall total of 38 patients having a CXR requested 
(49% of the whole cohort) over the 12-month intervention 
period. No further target wait appointments were made after the 
first call. 
Chest X-ray referral rates 
     A sensitivity analysis was undertaken showing that using 
season as a covariate did not affect the interpretation of the 
results (see appendix). Figures 1 and 2, respectively, show the 
chest X-ray referral rates, taking account of seasonality, for the 
intervention and non-intervention cohorts. For the intervention 
cohort, linear regressions showed there was no effect of time on 
the proportion of patients referred during the pre-intervention 
LQWHUYDO ȕ   &,   VXJJHVWLQJ D
steady rate of referral during this interval that was not signifi-
FDQWO\GLIIHUHQWIURP]HURLQWHUFHSW &, 
0.013).  However, the post-intervention interval saw higher 
UDWHV RI UHIHUUDO LQWHUFHSW     &,    
There was no significant change in the rate of referral during the 
SRVWLQWHUYHQWLRQ SHULRG ȕ   &,  
0.0003), although figure 1 suggests the possibility of a slowly 
decreasing trend in the rate of referral after the intervention, as 
may be expected. For the non-intervention cohort, there was a 
similar lack of effect of time on referral rates, for both the pre- 
ȕ &, DQGSRVWȕ 
 &,     LQWHUYHQWLRQ LQWHUYDOV  )RU WKLV
cohort, the baseline referral rate during the pre-intervention 
SHULRGZDVKLJKHUWKDQIRUWKHLQWHUYHQWLRQFRKRUWLQWHUFHSW 
  &,     EXW IRU WKH SRVWLQWHUYHQWLRQ
period, the baseline referral rate was slightly lower than for the 
Characteristic
Number of patients
Age at enrolment
    <55 yr
    55–59 yr 
    60–64 yr 
    65–69 yr
    70–74 yr 
    75–79 yr 
    80–84 yr 
\U
Sex
    Male
    Female
Smoking status
    Never
    Current
    Former
Pack-year smoking history 
     < 10
    10-20
    20-29
    30-39
    40-49
    50-59

Number (percent)
77 (100)
3 (4)
9 (12)
14 (18)
17 (22)
10 (13)
13 (17)
8 (10)
3 (4)
43 (56)
34 (44)
5 (6)
17 (22)
55 (71)
16 (20)
10 (13)
12 (16)
13 (17)
9 (12)
8 (10)
 9 (12)
Table 1. Baseline characteristics of the study participants  
Call Duration: number (percent)
Call number
1
2
3
4
<5 min
13(18)
8 (12)
3 (8)
3 (6)
5 - 9 min
54 (74)
58 (86)
35 (88)
48 (92)
10 - 15 min
6 (8)
1 (1)
1 (3)
1 (2)
Table 2. Call durations. The number of calls falling within the 
time ranges specified are shown, with the percentage of calls of 
that series in parenthesis
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Patients contacted
New persistent cough
Changed cough
Changed cough for >3 weeks
Haemoptysis
Chest pain
>2 kg weight loss
Chest X-ray ordered
Medical review
Lung cancer referral
Call 1
77 (100)
13 (17)
7 (9)
7 (9)
4 (5)
6 (8)
  8 (10)
21 (27)
1 (1)
4 (5)
Call 2
69(100)
5 (7)
2 (3)
2 (3)
1 (1)
3 (4)
6 (9)
6 (9)
  7 (10)
0 (0)
Call 3
40 (100)
1 (3)
2 (5)
1 (3)
2 (5)
1 (3)
3 (8)
1 (3)
    4(10)
  0 (0)
Call 4
52 (100)
4 (8)
1 (2)
1 (2)
2 (4)
1 (2)
1 (2)
4 (8)
  6 (12)
0 (0)
Call number 
Table 3. Numbers of patients contacted, symptoms identified and actions taken after each call. Values are absolute numbers 
(percentage of total numbers of calls)
Figure 1. dŚĞƉƌŽƉŽƌƟŽŶŽĨƉĂƟĞŶƚƐƌĞĨĞƌƌĞĚĨŽƌĂĐŚĞƐƚy ?ƌĂǇŝŶ
ƚŚĞŝŶƚĞƌǀĞŶƟŽŶĐŽŚŽƌƚŝŶƚŚĞ ? ?ŵŽŶƚŚƐƉƌŝŽƌƚŽƚŚĞŝŶƚĞƌǀĞŶ ?
ƟŽŶ ? ƚŚĞ ŝŶƚĞƌǀĞŶƟŽŶ  ?ďĞƚǁĞĞŶ ƚŚĞ ƌĞĚ ďĂƌƐ ? ĂŶĚ ƉŽƐƚ
ŝŶƚĞƌǀĞŶƟŽŶƉĞƌŝŽĚƐ ?ƚĂŬŝŶŐĂĐĐŽƵŶƚŽĨƐĞĂƐŽŶĂůŝƚǇ
Figure 2. dŚĞƉƌŽƉŽƌƟŽŶŽĨƉĂƟĞŶƚƐƌĞĨĞƌƌĞĚĨŽƌĂĐŚĞƐƚy ?ƌĂǇŝŶ
ƚŚĞ ŶŽŶ ?ŝŶƚĞƌǀĞŶƟŽŶ ĐŽŚŽƌƚ ŝŶ ƚŚĞ  ? ? ŵŽŶƚŚƐ ƉƌŝŽƌ ƚŽ ƚŚĞ
ŝŶƚĞƌǀĞŶƟŽŶŝŶƚŚĞŽƚŚĞƌĐŽŚŽƌƚ ?ƚŚĞŝŶƚĞƌǀĞŶƟŽŶƉĞƌŝŽĚŝŶƚŚĞ
ŽƚŚĞƌĐŽŚŽƌƚ ?ďĞƚǁĞĞŶƚŚĞƌĞĚďĂƌƐ ?ĂŶĚƚŚĞƉŽƐƚŝŶƚĞƌǀĞŶƟŽŶ
ƉĞƌŝŽĚƐ ?ƚĂŬŝŶŐĂĐĐŽƵŶƚŽĨƐĞĂƐŽŶĂůŝƚǇ
Figure 3.ZĞŐƌĞƐƐŝŽŶĐŽ ?ĞĸĐŝĞŶƚƐĂŶĚ/Ɛ ĨŽƌ ŝŶƚĞƌĐĞƉƚƐ  ?ďĂƐĞůŝŶĞƌĞĨĞƌƌĂů ƌĂƚĞƐ ? ĨŽƌ ŝŶƚĞƌǀĞŶƟŽŶĂŶĚŶŽŶ ?ŝŶƚĞƌǀĞŶƟŽŶĐŽŚŽƌƚƐ ?
ůĂĐŬƉŽŝŶƚƐƐŚŽǁƉƌĞ ?ŝŶƚĞƌǀĞŶƟŽŶďĂƐĞůŝŶĞ ?ƌĞĚƉŽŝŶƚƐƐŚŽǁƉŽƐƚŝŶƚĞƌǀĞŶƟŽŶďĂƐĞůŝŶĞ ?ŵƉƚǇĐŝƌĐůĞƐƐŚŽǁƌĞƐƵůƚƐĂĐĐŽƵŶƟŶŐĨŽƌ
ƐĞĂƐŽŶ ?ĮůůĞĚĐŝƌĐůĞƐƐŚŽǁƌĞƐƵůƚƐǁŝƚŚŽƵƚĞīĞĐƚƐŽĨƐĞĂƐŽŶ
Loganathan RS, Stover DE, Shi W, et al. Prevalence of COPD in women 1.
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LQWHUYHQWLRQFRKRUWLQWHUFHSW &, 
It is possible that the higher rates of referral in the non-interven-
tion cohort during the pre-intervention period may indicate 
some self-selection for the intervention by those patients who 
had had fewer referrals in the months prior to the study.  There 
appeared to be an increase in the referral rate for the non-inter-
vention cohort for the post-intervention period, compared with 
the pre-intervention period, but this rise was not nearly as 
marked as that seen in the intervention cohort (Figure 3). It is 
possible that this reflected an increased awareness of lung 
cancer as a concern in COPD patients amongst the primary care 
team.  
Discussion
  The primary aim of confirming the feasibility of a 
telephone-based programme of actively seeking potential lung 
cancer symptoms amongst patients included on a primary care 
COPD register was achieved. Minimal additional resource was 
required –mostly the time taken to make the calls by the 
practice nurse and extra reviews required by the practice 
doctors. Our study has shown a very high prevalence of symp-
toms for which NICE lung cancer guidelines recommend a 
chest X-ray or urgent secondary care referral, both at the initial 
call and subsequent ones. No increase in the chest X-ray rate 
was seen in COPD patients on the register who had not volun-
teered for the study. The increase in chest X-ray rate in the 
intervention group persisted over the 20 months after the 
intervention had finished, suggesting that participation in the 
study had led to a behavior change, presumably by breaking 
down barriers to disclosure of symptoms and an understanding 
of the appropriateness of attending for this investigation. 
      New symptoms continued frequently to be identified at the 
follow up calls and beyond. As “background symptoms” should 
have been accounted for, these new symptoms may potentially 
be more specific for new pathology. This would include lung 
cancer, but also, inevitably, exacerbations of COPD. 
       The main methodological finding was the low proportion of 
patients who consented to participate (27%), using the 2-stage 
consent process employed. In contrast, the practice manages to 
see about 80 % of these patients for their annual “QOF” checks 
through the use of up to 3 invitation letters as well as calls from 
administrative staff for non-attenders. The recruitment process 
will need to be modified for the next phase of the investigation. 
When calling patients there was always the difficulty of catch-
ing them in. Over the last 2 years the practice concerned, proba-
bly reflecting a more general trend, has dramatically increased 
their database of mobile phone numbers, reflecting the increase 
in use of triage calls prior to making appointments. Additional-
ly, text reminders are now employed and this method may well 
increase recruitment for the planned, definitive, clinical trial 
possibly augmented by the use of “cold calling” invited subjects 
by telephone.
      It seems likely that the uptake of the intervention would be 
improved if it could be “piggy-backed” onto the annual QOF 
review, thereby obviating much of the extra effort in reaching 
patients for the interviews. If the intervention were incorporated 
into standard clinical care in this way, the main additional 
resource required would be 2 additional calls per year, beyond 
the current annual review, requiring about 10 additional 
minutes of nurse time per COPD patient. 
         As expected from the small size of the study and its limited 
power, the differences seen, whilst promising, just fell short of 
statistical significance. Similarly, no new lung cancer cases 
were found. We believe this justifies a larger, fully randomised 
study.
         If this approach were confirmed to be effective in improv-
ing lung cancer diagnosis, it could potentially be funded 
through locally enhanced services or an extension of the QOF 
process. The time for the review of X-ray reports was minimal. 
We believe that the additional GP reviews of symptomatic 
patients may be particularly cost-effective, as many of these 
patients would eventually need review anyway and would 
merely be seen earlier. The annual COPD review is often 
carried out using a computerized template. Incorporating the 
additional questions, either as free text or a READ code 
question within a COPD template, would be a straightforward 
process and could be linked with a protocol to aide a decision to 
generate an X-ray request.
Conclusion
       The intervention was readily practicable and lung cancer 
symptoms were frequently identified. The intervention may 
have resulted in a behavior change leading to a persistently 
higher chest X-ray rate even after the intervention, although the 
comparator group was not a formal control group and further 
assessment in a randomized control trial appears justified.
    Abbreviations: COPD: chronic obstructive pulmonary 
disease, NICE: National Institute for Health and Care Excel-
lence, Chronic lymphatic leukaemia, NYHA: New York Health 
Association, CI: confidence interval, QOF: Quality Outcomes 
Framework
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